Bluejay Diagnostics Shares Rise 13% After Reverse Stock Split Announced
By Chris Wack Bluejay Diagnostics shares rose 13% to 29 cents after the company said its board of directors approved a reverse stock split at a ratio of...
Stay updated with breaking news from Bluejay Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Chris Wack Bluejay Diagnostics shares rose 13% to 29 cents after the company said its board of directors approved a reverse stock split at a ratio of...
BJDX | Complete Bluejay Diagnostics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Bluejay Diagnostics, Inc. (BJDX) shares are up 10% on Friday after the company approved a reverse stock split of its shares at a ratio of 1-for-20. The split will reduce the number of outstanding shares from 100 million to 7.
Lobbying revenues at K Street’s top firms began to rebound from a slower start to 2023, as lawmakers set to work on a slew of must-pass bills.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) saw a large decline in short interest in June. As of June 30th, there was short interest totalling 238,200 shares, a decline of 19.9% from the June 15th total of 297,200 shares. Currently, 2.1% of the company’s stock are short sold. Based on an average trading volume […]